Invesco Solar ETF (TAN) Stock Price Today
Trogenix appoints John Young as Chair and Josh Murray as Non-Executive Director to boost global growth and US expansion.
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
Wellington Management Group crosses 5% voting rights threshold in Admiral Group PLC shares.
Wellington Management Group LLP has notified that it crossed the 5% voting rights threshold in Admiral Group PLC as of November 6, 2026. The group holds a total of 5.01% voting rights through direct shares and financial instruments. This disclosure i...
Roche unveils new Alzheimer’s drug and diagnostic data at CTAD 2026, advancing treatment and early detection.
Roche presented new data on its Alzheimer’s disease portfolio at the CTAD 2026 conference, highlighting advances in both pharmaceuticals and diagnostics. Key updates include Phase Ib/IIa data for trontinemab showing rapid amyloid clearance, the start...
Valneva's chikungunya vaccine IXCHIQ® shows 94% antibody persistence five years after one dose
Valneva announced that 94% of participants maintained a strong antibody response five years after a single dose of its chikungunya vaccine IXCHIQ®. The vaccine showed durable immunity across all age groups, including adults over 65, supporting its po...
onsemi launches EliteSiC M4, boosting power density by 30% and cutting losses for EVs, AI, and energy sectors.
onsemi introduced its fourth-generation silicon carbide platform, EliteSiC M4, which offers up to 30% higher power density and 35% lower losses compared to its predecessor. This new technology enhances efficiency and power density for applications in...
FDA mandates vision loss warning on all GLP-1 drugs due to rare eye condition risk
The FDA requires all makers of GLP-1 medications to add warnings about a rare eye condition called nonarteritic anterior ischemic optic neuropathy (NAION), which can cause sudden and possibly permanent vision loss. This decision follows a review of c...
Baron Global Durable Advantage ETF falls 1.2% in Q3, underperforming MSCI ACWI Index.
Baron Global Durable Advantage ETF declined by 1.2% in the third quarter, underperforming the MSCI ACWI Index which gained 1.6%. The fund faced a sell-off in AI-related stocks and saw a 279 basis points underperformance due to poor stock selection an...
Trump says Iran war could end soon as talks progress and Iran's military weakens
U.S. President Donald Trump stated that the war with Iran could end "fairly soon," citing Iran's weakened military and ongoing polite talks with Washington. He highlighted the destruction of Iran's navy and economic struggles due to inflation as key ...
Quantinuum and RIKEN upgrade Reimei quantum computer, advancing Japan's quantum-AI hybrid supercomputing leadership.
Quantinuum and Japan's RIKEN have completed a major upgrade to the Reimei quantum computer, enhancing Japan's hybrid quantum-supercomputing platform to the world's most capable. This upgrade enables advanced research in electronics, energy, and life ...
Valneva's chikungunya vaccine IXCHIQ® shows 94% antibody persistence five years after one dose
Valneva SE reported that 94% of participants maintained a strong immune response five years after a single dose of its chikungunya vaccine IXCHIQ®. The vaccine showed durable antibody persistence across all age groups, including those over 65, suppor...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.